Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis.

about

Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis

P2860

Q58707093-BD79D310-2017-4809-8244-8A2B5B66E376

P2860

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis.

Item

http://www.wikidata.org/entity/Q48147122

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Fecal Calprotectin: A Reliable ...... for Active Ulcerative Colitis.

@en

Fecal Calprotectin: A Reliable ...... for Active Ulcerative Colitis.

@nl

type

Item

label

Fecal Calprotectin: A Reliable ...... for Active Ulcerative Colitis.

@en

Fecal Calprotectin: A Reliable ...... for Active Ulcerative Colitis.

@nl

prefLabel

Fecal Calprotectin: A Reliable ...... for Active Ulcerative Colitis.

@en

Fecal Calprotectin: A Reliable ...... for Active Ulcerative Colitis.

@nl

P1476

Fecal Calprotectin: A Reliable ...... for Active Ulcerative Colitis.

@en

P2093

Arne Røseth

http://www.w3.org/2001/XMLSchema#string

Tahir Ahmad

http://www.w3.org/2001/XMLSchema#string

Vendel Kristensen

http://www.w3.org/2001/XMLSchema#string

Viggo Skar

http://www.w3.org/2001/XMLSchema#string

P2860

A simple clinical colitis activity index

Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease.

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study.

Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis.

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

European evidence based consensus for endoscopy in inflammatory bowel disease.

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.

Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis.

P304

2098293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/2098293

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Bjørn Moum

P577

2017-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29225617

http://www.w3.org/2001/XMLSchema#string

P921

Aka

P932

5684574

http://www.w3.org/2001/XMLSchema#string

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis.

about

P2860

P2860

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932